Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Filings indexed 1,550 across all filing types
Latest filing 2021-02-09 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Bodal Chemicals Limited has informed the Exchange about Acquisition
Regulatory Filings
2021-02-09 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding a Business Transfer Agreement (BTA) for the acquisition of a chemical plant from Mawana Sugar Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content includes details about the acquisition such as the target entity, consideration, cost, and background information. There are no financial statements or detailed financial analysis present, only an announcement of the transaction. The document length is about 9992 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. This fits the category of Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through acquisition. It is not an Annual Report, Interim Report, or Regulatory Filing as it is a specific transaction disclosure. Therefore, the correct classification is CAP with high confidence.
2021-02-09 English
Statement of deviation(s) or variation(s) under Reg. 32
Capital/Financing Update Classification · 95% confidence The document is a statement regarding the deviation or variation in the utilization of funds raised through a preferential allotment of equity warrants by Bodal Chemicals Limited. It includes details such as the mode of fund raising, date of raising funds, amount raised, and a report filed for the quarter ended December 31, 2021. The content focuses on fund utilization and compliance with the original objectives of the fund raising. This type of document is typically categorized under Capital/Financing Update (CAP) as it provides updates on the use of capital raised through financing activities. The document is not a full financial report, audit report, or regulatory filing but a specific update on capital usage.
2021-02-09 English
Bodal Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings
2021-02-09 English
Press Release
Regulatory Filings Classification · 90% confidence The document contains only a brief table listing product names and their installed capacities, with no mention of any report type, regulatory body, financial data, or corporate announcements. The length is very short (300 characters), and there is no indication that this is a report or announcement related to financial or corporate filings. It appears to be a simple product capacity summary without any filing context. Therefore, it does not fit into any specific detailed filing category and best fits the fallback category for miscellaneous filings.
2021-02-09 English
Bodal Chemicals Limited has informed the Exchange regarding a press release dated February 09, 2021.
Regulatory Filings
2021-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.